SCHEMBL9239138

SCHEMBL9239138

CCCNCCCCCCCCCCCC(N)(N)CCCNCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
ALDH1A1 P00352 1/20 0.46
PAOX Q6QHF9 1/20 0.42
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 3/20 0.39
RELA Q04206 4/20 0.36
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
S1PR2 O95136 5/20 0.35
S1PR4 O95977 5/20 0.35
S1PR1 P21453 5/20 0.35
S1PR3 Q99500 5/20 0.35
S1PR5 Q9H228 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CA12 O43570 2/20 0.35
F13A1 P00488 2/20 0.35
CA2 P00918 2/20 0.35
ALOX15 P16050 2/20 0.35
CA4 P22748 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9239450 1.00 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19CYP1A2
SCHEMBL9106221 1.00 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19CYP1A2
SCHEMBL9240291 1.00 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19CYP1A2
SCHEMBL8405316 0.86 CYP2C19 (0.56) TSHRALDH1A1CYP2C19CYP1A2RELA
SCHEMBL8406010 0.86 CYP2C19 (0.56) TSHRALDH1A1CYP2C19CYP1A2RELA
SCHEMBL9239015 0.86 CYP2C19 (0.56) TSHRALDH1A1CYP2C19CYP1A2RELA
SCHEMBL9238051 0.86 CYP2C19 (0.56) TSHRALDH1A1CYP2C19CYP1A2RELA
SCHEMBL6722894 0.80 ALDH1A1 (0.56) TSHRALDH1A1CYP2C19CYP1A2RELA
SCHEMBL19878669 0.80 TSHR (0.44) TSHRALDH1A1PAOXCYP2C19CYP1A2
SCHEMBL19878661 0.80 TSHR (0.44) TSHRALDH1A1PAOXCYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995009832-A1 NOVEL PROCESS FOR PREPARING POLYAMINE DERIVATIVES AND INTERMEDIATES THEREOF MERRELL DOW PHARMACEUTICALS INC. (US) 1995-04-13 WO disclosed